Studies in mice demonstrate that signals from the bacteria that harmlessly-and often beneficially-inhabit the human gastrointestinal tract boost the immune system's ability to kill a major respiratory pathogen, Klebsiella pneumoniae, according to a paper published online ahead of print in the journal Infection and Immunity. The research is yet another example of how important these "commensal" bacteria are to human health and physiology, says Thomas B. Clarke, of Imperial College London, UK, the author of this paper.
"Numerous studies have shown that changes in the composition of the bacterial groups which colonize our gastrointestinal tract are linked to numerous systemic diseases and conditions outside of the intestine," says Clarke, describing the rationale for this research. "What has often been missing is a mechanistic understanding of how these bacteria can actively shape the physiology of their host, and this is what I wanted to address. I was interested in finding out how commensal bacteria help protect us from infection by pathogenic bacteria."
"Alveolar macrophages are the lungs' first line of defense against bacterial infection," says Clarke. "I found that the production of reactive oxygen molecules by these cells was enhanced by these signals from the commensal bacteria."
Reactive oxygen molecules are highly toxic molecules produced by our immune systems to kill bacteria and help protect against infection, but they can also cause collateral damage to our tissues, says Clarke. This means their production must be tightly regulated, in order to kill bacteria without doing major damage to lung tissue.
"This work shows that signals from commensal bacteria are part of this regulation and help establish the appropriate level of immune activation," says Clarke.
Recent studies by others had shown that changes in the composition of the gut bacteria cause changes in the alveolar macrophages that boost allergic inflammation in the airway, indicating that alterations of the commensal bacteria could result in immune response gone awry.
In this study, Clarke gave mice antibiotics to kill most of the commensal bacteria in their gastrointestinal tracts. That, he found, reduced the ability of alveolar macrophages to kill K. pneumoniae, demonstrating that the commensal bacteria were somehow involved in this immune response.
In order to determine exactly what component of the commensal bacteria was needed to boost this immune response, Clarke gave the antibiotic-treated mice a series of different highly conserved compounds from bacteria, one at a time. He found that one particular compound, a major component of the bacterial cell wall, called peptidoglycan, boosted the immune response of these microbially-impoverished mice. Peptidoglycan is found in just about all bacteria, including commensals.
"Previously, it was generally considered that recognition of conserved bacterial components was a way for the immune system to detect the presence of pathogens. However, the work in this study is part of an emerging area of research that suggests that these bacterial molecules play an active role in constantly regulating immune function, even in the absence of infection," says Clarke.
The final version of the article is scheduled for the November 2014 issue of Infection and Immunity.
Source: American Society for Microbiology (ASM)
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.